SCHEMBL808326

SCHEMBL808326

C=C(/N=C(N)\N=C(/N)c1noc(-c2ccccn2)n1)Nc1cc(Cl)ccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 8/20 0.38
NPC1 O15118 6/20 0.36
RAB9A P51151 6/20 0.36
TP53 P04637 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MAPT P10636 3/20 0.36
PKM P14618 2/20 0.36
MITF O75030 1/20 0.36
TSHR P16473 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
FAAH O00519 1/20 0.34
CES1 P23141 1/20 0.34
GRIK1 P39086 2/20 0.33
SLC2A1 P11166 1/20 0.32
MAPK1 P28482 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CA12 O43570 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL795559 0.67 GRM5 (0.47) GRM5NPC1RAB9ATP53SMN1; SMN2
SCHEMBL25177259 0.64 GRM5 (0.57) GRM5NPC1RAB9ATP53SMN1; SMN2
SCHEMBL808315 0.62 SMN1; SMN2 (0.39) NPC1RAB9ASMN1; SMN2TSHRHPGD
SCHEMBL27775431 0.61 GRIK1 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1HPGD
SCHEMBL29901533 0.57 CCR1 (0.52) GRM5NPC1RAB9ATP53SMN1; SMN2
SCHEMBL28115227 0.57 CCR1 (0.52) GRM5NPC1RAB9ATP53SMN1; SMN2
SCHEMBL4188067 0.57 GRM5 (0.72) GRM5NPC1RAB9ATP53SMN1; SMN2
SCHEMBL4194624 0.57 GRM5 (0.72) GRM5NPC1RAB9ATP53SMN1; SMN2
SCHEMBL1424895 0.57 TP53 (0.77) GRM5NPC1RAB9ATP53SMN1; SMN2
SCHEMBL30821175 0.56 GRM5 (1.00) GRM5NPC1RAB9ATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012035023-A1 TRIAZINE-OXADIAZOLES NOVARTIS AG (CH) 2012-03-22 WO disclosed